Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

1,161 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Host defence peptides: antimicrobial and immunomodulatory activity and potential applications for tackling antibiotic-resistant infections.
Nijnik A, Hancock R. Nijnik A, et al. Among authors: hancock r. Emerg Health Threats J. 2009;2:e1. doi: 10.3134/ehtj.09.001. Epub 2009 Feb 24. Emerg Health Threats J. 2009. PMID: 22460279 Free PMC article.
The therapeutic potential of cationic peptides.
Hancock RE. Hancock RE. Expert Opin Investig Drugs. 1998 Feb;7(2):167-74. doi: 10.1517/13543784.7.2.167. Expert Opin Investig Drugs. 1998. PMID: 15991950
Cationic peptides: effectors in innate immunity and novel antimicrobials.
Hancock RE. Hancock RE. Lancet Infect Dis. 2001 Oct;1(3):156-64. doi: 10.1016/S1473-3099(01)00092-5. Lancet Infect Dis. 2001. PMID: 11871492 Review.
Interaction of cationic antimicrobial peptides with model membranes.
Zhang L, Rozek A, Hancock RE. Zhang L, et al. Among authors: hancock re. J Biol Chem. 2001 Sep 21;276(38):35714-22. doi: 10.1074/jbc.M104925200. Epub 2001 Jul 25. J Biol Chem. 2001. PMID: 11473117
The role of cationic antimicrobial peptides in innate host defences.
Hancock RE, Diamond G. Hancock RE, et al. Trends Microbiol. 2000 Sep;8(9):402-10. doi: 10.1016/s0966-842x(00)01823-0. Trends Microbiol. 2000. PMID: 10989307 Review.
Cationic antimicrobial peptides: towards clinical applications.
Hancock RE. Hancock RE. Expert Opin Investig Drugs. 2000 Aug;9(8):1723-9. doi: 10.1517/13543784.9.8.1723. Expert Opin Investig Drugs. 2000. PMID: 11060771 Review.
In vitro characterization of the anticancer activity of membrane-active cationic peptides. I. Peptide-mediated cytotoxicity and peptide-enhanced cytotoxic activity of doxorubicin against wild-type and p-glycoprotein over-expressing tumor cell lines.
Johnstone SA, Gelmon K, Mayer LD, Hancock RE, Bally MB. Johnstone SA, et al. Among authors: hancock re. Anticancer Drug Des. 2000 Apr;15(2):151-60. Anticancer Drug Des. 2000. PMID: 10901303
1,161 results
Jump to page